Viral hepatitis, particularly that due to HBV or HCV, is a significant
problem in the UK population of IVDUs and alcohol misusers. Patients
attending drug rehabilitation clinics should be screened for HBV and H
CV infection. All those found to be HBcAb negative should be vaccinate
d against HBV. Those found to be HBsAg or HCV antibody positive should
have their liver function tests (LFTs) checked and be referred to a s
pecialist liver clinic for further evaluation. Interferon treatment of
HBV or HCV infection is effective in a proportion of cases but it is
an expensive agent that requires careful monitoring. Current managemen
t regimes are centred around the modification of risk behaviour and th
e identification of those most in need of, and most likely to respond
to, anti-viral treatment. Several new anti-viral agents are currently
undergoing clinical evaluation and this together with the prospect of
vaccines designed to clear an established infection means that the nex
t few years are likely to see some major advances in the treatment of
chronic viral hepatitis.